Belagavi firm Aequs gets approval for ₹650-crore equity infusion
By United One News · AI-generated summary of 1 outlets' reporting
Published
AI-generated summary of the coverage listed below:
- Belagavi firm Aequs received approval for a ₹650‑crore equity infusion.
- The funds will be used to expand its aerospace and consumer capacity and to support its borrowing programme.
Covered by 1 outlet across the spectrum: 100% left, 0% center, 0% right.
How each side framed it
Belagavi firm Aequs gets approval for ₹650-crore equity infusion
Timeline
First reported by The Hindu on ; 1 article from 1 outlets so far.
Who is covering this story
- Left-leaning (1): The Hindu
Sources
- Belagavi firm Aequs gets approval for ₹650-crore equity infusion — The Hindu (left-leaning) ·